Navigation Links
Intradigm Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property From University of Massachusetts Medical School
Date:4/9/2008

ent of specific ligands directed to target cell receptors. An additional key strength of the RNAi NPX delivery technology is its ability to incorporate multiple siRNAs in a single drug product. These multi-targeted therapeutics can simultaneously silence several mRNAs that represent parallel or synergistic elements of the same disease pathway resulting in a more comprehensive and/or novel therapeutic potential.

Recent technology licensing agreements with institutions such as the University of Massachusetts Medical School and the Massachusetts Institute of Technology have enhanced Intradigm's existing intellectual property portfolio and provided Intradigm with the rights and know-how to leverage a broad family of polymers and polymer structures, as well as next generation siRNA structures, in connection with its RNAi Nanoplex delivery technology.

ABOUT INTRADIGM

Intradigm is a private biotechnology company dedicated to the development of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases with an initial focus on oncology.

At present, Intradigm is working to build a high-value internal pipeline of RNAi oncology therapeutics, and is actively advancing its lead drug candidate, ICS-283, for a variety of cancer indications. The company is pursuing a comprehensive integrated RNAi therapeutic development strategy that incorporates advanced RNAi delivery technology, RNAi structural technology and novel, proprietary therapeutic siRNA sequences. For more information on Intradigm, please visit http://www.intradigm.com.

ABOUT THE UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL

The University of Massachusetts Medical School, one of the fastest growing academic health centers in the country, has built a reputation as a world-class research institution, consistently producing noteworthy advances in clinical and basic research. The Medical School attra
'/>"/>

SOURCE Intradigm Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
3. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
4. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
5. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
6. Protherics Licenses its CoVaccine HT Adjuvant to Nobilon for Influenza Vaccine Indications
7. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
8. Syngenta Licenses Chromatin Gene Stacking Technology
9. Utrecht University Licenses MetaDrug From GeneGo for Drug Innovation
10. Prometheus Licenses COLAL-PRED(R) From Alizyme
11. Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... (PRWEB) June 19, 2013 Express Diagnostics ... tests, today announced that it has received Class III ... and sell its DrugCheck® NxStep Onsite Drug Screen ... of the rapid screening device in near-patient settings, such ... Screen Cup received Health Canada Class III approval for ...
(Date:6/18/2013)... (Monday, June 17, 2013) A million electric cars could ... the decade with the help of research by the United ... University of Waterloo. , Professor Zhongwei Chen is part of ... to develop non-precious materials to replace the expensive platinum catalysts ... the adoption of fuel cells in vehicles is the cost ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 (PRWEB) June 18, 2013 ... time and attendance system in North America, has ... shares employee data and payroll records between ExakTime’s ... Plus automates ExakTime software setup and keeps ... imports employee data from a business’ current payroll ...
(Date:6/18/2013)... FL (PRWEB) June 18, 2013 The human ... the skin as an important human body part. Similar to ... for in order to function, repair and grow. Recent reports ... vitamins and supplements, is just as important as other life ... supplements to aid in skin cell reproduction, increase the appearance ...
Breaking Biology Technology:Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3US and Canadian researchers drive towards cheaper fuel cells for electric cars 2ExakTime Introduces AccountLinx Plus 2Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin 2
... LA JOLLA, Calif., Feb. 11 Cordex Pharma, Inc. ... a Medical Advisory Board to provide clinical guidance for ... of heart failure.The Medical Advisory Board will play an ... the planned CDP-1050 Phase 2 clinical trial and assist ...
... GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an ... for diseases caused by HIV-1 (Human Immunodeficiency Virus) ... McNally, Ph.D., Chief Executive Officer and President, presented ... CEO & Investor Conference 2009, held at the ...
... AMSTERDAM, The Netherlands, February 11, Agendia, a world ... of Alan B. Carter as the company,s new ... "As we continue to grow as ... primary aims," commented Dr. Bernhard Sixt, Ph.D., President ...
Cached Biology Technology:Cordex Pharma Forms Heart Failure Medical Advisory Board 2Cordex Pharma Forms Heart Failure Medical Advisory Board 3Cordex Pharma Forms Heart Failure Medical Advisory Board 4Cordex Pharma Forms Heart Failure Medical Advisory Board 5GeoVax Update Provided at the BIO CEO & Investor Conference 2009 2GeoVax Update Provided at the BIO CEO & Investor Conference 2009 3GeoVax Update Provided at the BIO CEO & Investor Conference 2009 4GeoVax Update Provided at the BIO CEO & Investor Conference 2009 5Agendia Appoints VP of Business Development 2
(Date:6/19/2013)... The PETA International Science Consortium (PISC) is extremely ... of Appeal has upheld a decision that requires ... study in rats. The study will use approximately ... unborn pups to the substance dipropylene glycol methyl ... the European Community,s Regulation on the Registration, Evaluation, ...
(Date:6/19/2013)... University of Pittsburgh has developed antibacterial compounds, derived ... be potential treatments for drug-resistant bacterial infections and ... are quite small, making them inexpensive and easy ... June 2013 issue of the journal Antimicrobial ... many probable applications will likely be the chronic ...
(Date:6/19/2013)... new variety of canary seeds bred specifically for human ... ideal for people with celiac disease (CD), scientists have ... of Agricultural and Food Chemistry . , Joyce ... 3 million people in the United States alone have ... wheat, barley, rye and other grains that contain gluten-related ...
Breaking Biology News(10 mins):HIV-derived antibacterial shows promise against drug-resistant bacteria 2
... Ore. The rearing of steelhead trout in hatcheries ... ability to reproduce in the wild, a new Oregon ... the wisdom of historic hatchery practices. The research, ... for the first time that the reproductive success of ...
... America (ESA) is proud to announce its selection of ... Selection as an ESA Fellow acknowledges outstanding contributions in ... who have have participated actively in ESA affairs and ... will be recognized during the ESA Annual Meeting, which ...
... worldwide and rank as number one in terms ... a recent ECNP commissioned report has demonstrated (Wittchen ... greatest decrement in health compared with the common ... (Moussavi et al., 2007) followed by addictive disorders ...
Cached Biology News:Salmonid hatcheries cause 'stunning' loss of reproduction 2Salmonid hatcheries cause 'stunning' loss of reproduction 3Entomological Society of America recognizes 2007 fellows and honorary members 2Entomological Society of America recognizes 2007 fellows and honorary members 320th ECNP Congress 2007, Oct. 13-17, Vienna, Austria 220th ECNP Congress 2007, Oct. 13-17, Vienna, Austria 320th ECNP Congress 2007, Oct. 13-17, Vienna, Austria 4